Phase 1 Study of Nelfinavir Concurrent With Temozolomide and Radiation Therapy in Patients With Glioblastoma Multiforme

被引：0
|
作者：
Fang, P. [1 ]
Alonso-Basanta, M. [1 ]
Maity, A. [1 ]
Hahn, S. [1 ]
Lustig, R. [1 ]
Dorsey, J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2013年 / 87卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2013.06.051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Alonso-Basanta, Michelle
    Fang, Penny
    Maity, Amit
    Hahn, Stephen M.
    Lustig, Robert A.
    Dorsey, Jay F.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 365 - 372
  • [2] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Michelle Alonso-Basanta
    Penny Fang
    Amit Maity
    Stephen M. Hahn
    Robert A. Lustig
    Jay F. Dorsey
    [J]. Journal of Neuro-Oncology, 2014, 116 : 365 - 372
  • [3] Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
    Jastaniyah, Noha
    Murtha, Albert
    Pervez, Nadeem
    Le, Duc
    Roa, Wilson
    Patel, Samir
    Mackenzie, Marc
    Fulton, Dorcas
    Field, Colin
    Ghosh, Sunita
    Fallone, Gino
    Abdulkarim, Bassam
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [4] Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
    Noha Jastaniyah
    Albert Murtha
    Nadeem Pervez
    Duc Le
    Wilson Roa
    Samir Patel
    Marc Mackenzie
    Dorcas Fulton
    Colin Field
    Sunita Ghosh
    Gino Fallone
    Bassam Abdulkarim
    [J]. Radiation Oncology, 8
  • [5] Phase I Study of Hypofractionated Intensity Modulated Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Glioblastoma Multiforme
    Jastaniyah, N. T.
    Le, D.
    Pervez, N.
    Roa, W.
    Murtha, A.
    Patel, S.
    Mackenzie, M.
    Fulton, D.
    Field, C.
    Fallone, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S168 - S168
  • [6] A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME
    Krauze, Andra V.
    Myrehaug, Sten D.
    Chang, Michael G.
    Holdford, Diane J.
    Smith, Sharon
    Shih, Joanna
    Tofilon, Peter
    Fine, Howard
    Camphausen, Kevin A.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [7] Concurrent Temozolomide and Radiation, a Reasonable Option for Elderly Patients With Glioblastoma Multiforme?
    Kimple, Randall J.
    Grabowski, Sarah
    Papez, Michael
    Collichio, Frances
    Ewend, Matthew G.
    Morris, David E.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03): : 265 - 270
  • [8] Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei Yin
    Parvataneni, R.
    Hristova-Kazmierski, Maria
    Musib, Luna
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    [J]. NEURO-ONCOLOGY, 2010, 12 (06) : 608 - 613
  • [9] NEOADJUVANT (PRE RADIOTHERAPY) TEMOZOLOMIDE FOLLOWED BY RADIATION THERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME
    Prajapati, Chinmaykumar
    Mehta, Maitrik
    Kunikullaya, U. Suryanarayan
    [J]. NEURO-ONCOLOGY, 2021, 23 : 45 - 45
  • [10] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
    Peereboom, D. M.
    Brewer, C. J.
    Sub, J. H.
    Stevens, G. H.
    Barnett, G. H.
    Toms, S. A.
    Elson, P.
    Vogelbaum, M. A.
    Weil, R. J.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
12345